METTL14 and colorectal carcinoma: METTL14, along with METTL3, affects the number of CD8+ T cells infiltrating into tumors since its depletion led to an increase of CD8+ T cells, in addition to as well as IFN‐γ, CXCL9 and CXCL10 in colorectal cancer (CRC) (13).